Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Accuracy of psychometric tools in the assessment of personality in adolescents and adults requesting gender-affirming treatments: A systematic review

  • Katrin Lehmann, Gerard Leavey
  • Journal:
    European Psychiatry / Volume 62 / October 2019
    Published online by Cambridge University Press:
    01 January 2020, pp. 60-67
    • Article
      • You have access
    • PDF
    • HTML
    • Export citation
  • Background:

    The assessment and screening for personality disorders in individuals requesting gender affirming treatments may be an important aspect of predicting medical and surgical outcomes for this population, but there is no consensus on how best to do so.

    Aims:

    To review the diagnostic accuracy of psychometric tools used for the assessment of personality disorders in those requesting gender affirming treatments.

    Method:

    A systematic review: Prospero CRD42017078783 [1].

    Results:

    Many studies have focussed on the assessment of personality disorders in this population, but since 1979, only two have used an index and reference test.

    Conclusion:

    There are no agreed reference standards for this population and psychometric tools continue to be scored on reference data from the cisgender (not transgender) population. We need robust evidence on this issue, as individuals may be denied access to gender affirming treatments based on psychometric tools without established reliability in this population.

  • Chapter 20 - Management of psychiatric syndromes due to endocrine and metabolic diseases

  • Edited by James J. Amos, University of Iowa, Robert G. Robinson, University of Iowa
  • Book:
    Psychosomatic Medicine
    Published online:
    04 August 2010
    Print publication:
    27 May 2010, pp 184-192

  • Summary

    The first step in treating a patient with Parkinson's disease (PD) and psychiatric symptoms is ensuring that the patient actually has PD. No disease-modifying treatments or neuroprotective drugs exist for PD. Treatments include levodopa; dopamine agonists such as pramipexole, ropinirole, and apomorphine; monoamine oxidase inhibitors such as seligiline and rasagaline; and glutamatergic antagonists such as amantadine. Psychiatric symptoms are highly prevalent in PD, but are often unrecognized and undertreated, and are easily missed if not specifically investigated. Psychotherapy is evidence based treatment for many idiopathic psychiatric disorders, and does not cause side effects or worsen motor symptoms. The specific psychiatric disorders in Parkinson's disease are: mood disorders, anxiety disorders, psychotic disorders and cognitive disorders. The other psychiatric symptoms in Parkinson's disease are: delirium, sleep disorders, and sexual disorders.